Tolerance of spironolactone
Authors:
- 1 May 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 118 (5) , 687-691
Abstract
A survey of 54 patients taking spironolactone for hirsutes or acne showed that side-effects occurred in 91%; in 80% of patients, these were related to the anti-androgenic mechanism of the drug (menstrual disturbances, and breast enlargement and tenderness). The concomitant use of a contraceptive pill gave a lower incidence of menstrual abnormalities. Only seven patients (13%) had to stop the drug. In a further eight patients, a reduction in dose to between 125 and 175 mg daily achieved a compromise of controlling the disease and the side-effects. Side-effects tended to occur early and so regular review during the initial 3 months of treatment is advised. Two patients in our study developed 'chloasma'--a previously unreported complication of spironolactone. This was the only side-effect which occurred late in treatment.Keywords
This publication has 6 references indexed in Scilit:
- Oral spironolactone: an effective treatment for acne vulgaris in womenBritish Journal of Dermatology, 1986
- 10 Treatment of hirsutism with spironolactoneClinics in Endocrinology and Metabolism, 1986
- Spironolactone in combination drug therapy for unresponsive hirsutismFertility and Sterility, 1985
- Oral spironolactone improves acne vulgaris and reduces sebum excretionBritish Journal of Dermatology, 1984
- Treatment of hirsutism with spironolactoneJAMA, 1982
- Antiandrogenic Effect of Spirolactones: Mechanism of ActionEndocrinology, 1975